Scientific Advisory Board |

Jay George, Ph.D.

Dr. George is currently the Chief Technology Officer for Trevigen. He was most recently the Chief Scientific Office of American Type Culture Collection (ATCC), a global nonprofit bioresource center containing the largest and most diverse collection of biological materials in the world. His vast knowledge of cell culturing and strong relationships with leading research institutions within the various disciplines of life sciences will bring tremendous benefits to the company. His previous work experience includes Assistant Director for Program Technology Development at the National Cancer Institute and Vice President Research and Development at both Condon Pharmaceuticals and Oncor. Jay George has published numerous articles and holds the patents for a number of leading biotechnology procedures and products.


Anne Kopf-Sill, Ph.D.

Dr. Kopf-Sill brings two decades of experience in developing increasingly complex research and diagnostic products. She was most recently with CellPoint Diagnostics as President & VP of R&D and Operations. Previous, she was with NuGEN Technologies as the Vice President of New Products, as well as Caliper Life Sciences where she successfully led the development of new assay and microfluidics products, and managed the technical development in strategic collaborations. She is an inventor on more than 30 microfluidics and diagnostic patents and was recently elected as President of the Association for Laboratory Automation. Dr. Kopf-Sill earned a Ph.D. and M.S. in Chemical Engineering from Stanford University. In addition, she received a B.S. from the University of Virginia in Chemical Engineering.


James Trimarchi, Ph.D.

Dr. Trimarchi is a laboratory operational specialist certified in Six-Sigma Improvement approaches. He was most recently a director of the in vitro Fertilization (IVF) Laboratory at Women and Infants' Hospital where he pioneered metric-drive quality improvement strategies that have established a new benchmark for clinical laboratories. Presently, Dr. Trimarchi is an independent consultant for healthcare and biotechnology laboratories to improve quality and assure patient safety while reducing operational expenditures. In addition, he has authored over 35 peer-reviewed scientific journals, notable speaker as a thought leader in innovation and process control globally, and recipient of both commercial and private grants.


Copyright 2016 Global Cell Solutions, Inc. | Site by: fjguzzone.com